中文产业新闻精选评分68Chinese source
恒瑞医药口服GLP-1受体激动剂safiglipron三期OUTSTAND-1试验显示降糖与体重获益
连发两篇Nature Medicine：恒瑞医药口服小分子GLP-1受体激动剂，为2型糖尿病带来治疗新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
连发两篇Nature Medicine：恒瑞医药口服小分子GLP-1受体激动剂，为2型糖尿病带来治疗新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.